SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-043023
Filing Date
2024-05-14
Accepted
2024-05-14 17:03:18
Documents
61
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0205885-10q_adialpharma.htm   iXBRL 10-Q 418383
2 CERTIFICATION ea0205885ex31-1_adialpharma.htm EX-31.1 11798
3 CERTIFICATION ea0205885ex31-2_adialpharma.htm EX-31.2 11488
4 CERTIFICATION ea0205885ex32-1_adialpharma.htm EX-32.1 4799
5 CERTIFICATION ea0205885ex32-2_adialpharma.htm EX-32.2 4723
  Complete submission text file 0001213900-24-043023.txt   3742745

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adil-20240331.xsd EX-101.SCH 39389
7 XBRL CALCULATION FILE adil-20240331_cal.xml EX-101.CAL 32199
8 XBRL DEFINITION FILE adil-20240331_def.xml EX-101.DEF 205249
9 XBRL LABEL FILE adil-20240331_lab.xml EX-101.LAB 369673
10 XBRL PRESENTATION FILE adil-20240331_pre.xml EX-101.PRE 198483
65 EXTRACTED XBRL INSTANCE DOCUMENT ea0205885-10q_adialpharma_htm.xml XML 283448
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 24945539
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)